methyllycaconitine has been researched along with malondialdehyde in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arcaro, V; Ballabeni, V; Barocelli, E; Bertoni, S; Cantoni, AM; Domenichini, G; Flammini, L; Rapalli, A; Saccani, F; Tognolini, M; Vivo, V | 1 |
| Guan, ZZ; Tan, LC; Xiao, Y; Xiu, J; Zhao, L | 1 |
2 other study(ies) available for methyllycaconitine and malondialdehyde
| Article | Year |
|---|---|
Suppression of inflammatory events associated to intestinal ischemia-reperfusion by 5-HT1A blockade in mice.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Buspirone; Female; Heme Oxygenase-1; Interleukin-1beta; Intestinal Mucosa; Intestines; Malondialdehyde; Membrane Proteins; Mice; Nicotinic Antagonists; Peroxidase; Piperazines; Receptor, Serotonin, 5-HT1A; Reperfusion Injury; Serotonin; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT1 Receptor Antagonists; Tumor Necrosis Factor-alpha | 2014 |
Protection against the Neurotoxic Effects of β-Amyloid Peptide on Cultured Neuronal Cells by Lovastatin Involves Elevated Expression of α7 Nicotinic Acetylcholine Receptors and Activating Phosphorylation of Protein Kinases.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Amyloid beta-Peptides; Animals; Animals, Newborn; Butadienes; Cell Death; Cell Line, Tumor; Cell Survival; Cells, Cultured; Cholesterol; Humans; Lovastatin; Malondialdehyde; MAP Kinase Signaling System; Nerve Tissue Proteins; Neurons; Neuroprotection; Neuroprotective Agents; Neurotoxins; Nitriles; Phosphorylation; Protein Kinases; Rats, Sprague-Dawley; RNA, Messenger; RNA, Small Interfering; Superoxide Dismutase | 2018 |